CTSO
CytoSorbents' Q4 2025 Review: Strong Sales Growth, Regulatory Progress, and PuriFi Expansion
CytoSorbents, a leading developer of blood purification technologies, has reported strong sales growth and significant regulatory progress in its fourth quarter and full year 2025 performance. According to the company's Q4 2025 conference call transcript, CytoSorbents' Chief Executive Officer, Dr. Phillip Chan, highlighted the key priorities achieved